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As part of innate immunity, the complement system embod-
ies the “�rst line of defense” to various initial insults, includ-
ing trauma, infection, hemorrhage, ischemia, and autoim-
munity. While of bene�cial intention, excessive complement
activation can inadvertently damage healthy host tissues and
thereby exacerbate the initial pathological events by causing
an “innocent bystander effect.”
“Complementology” represents a rapidly evolving �eld.
Recent scienti�c efforts have identi�ed novel complement
activation pathways and select complement-inhibiting com-
pounds, which have been shown to ameliorate myriad
autoimmune or in�ammatory conditions. ese �ndings
have renewed the enthusiasm for novel pharmacologi-
cal strategies targeting numerous in�ammatory conditions,
which currently elude successful transfer “from bench to
bedside,” such as acute lung injury, sepsis, burn, ischemia-
reperfusion injury, traumatic brain injury, and kidney dis-
ease.
e abundant involvement of the complement system in
human health and disease is re�ected by the wide range of
topics covered in this special issue of Clinical and Develop-
mental Immunology.
B. Nilsson and N. Ekdahl provide a summarizing article
on current indications, techniques, sampling, and interpre-
tations for clinical complement analyses. In addition, an
easy-to-follow algorithm is provided for routine laboratory
operations.
G. Cazander et al. illustrate the success of targeted
complement inhibition of complement in wound healing
and demonstrate how revesal of complement hyperactivity
using several complement inhibitors has resulted in novel and
innovative wound care strategies, which may soon be subject
of clinical trials.
K. J. Welsh et al. challenge recent evidence that com-
plement plays a critical role in the host defense against
Mycobacterium tuberculosis. Following aerosol challengewith
Mycobacterium tuberculosis, the authors demonstrate that
“C7-knockout” mice had markedly reduced liver colony
forming units and lung occlusion in conjunction with signif-
icantly increased total lymphocytes, decreased macrophages,
and increased numbers of CD4+ cells. In line, expression
of lung IFN-𝛾𝛾 and TNF-𝛼𝛼 was increased in these animals,
underscoring a crucial role of C7 in the disease manifestation
ofMycobacterium tuberculosis.
S. R. Stowell et al.’s manuscript reviews the role of
complement in transfusion-related mortality. is is of par-
ticular interest, as excessive complement activation during
transfusion represents one of the most common features
associated with fatality.e treating physician is furthermore
provided with several strategies aiming to immunomodulate
the complement system during incompatible red blood cell
transfusions.
In two reviews, F. Bu et al. and S. F. Heeringa and
colleagues review complement involvement in renal disease.
Bu reviews the pathogenetic role of genetic variations in
complement genes and complement dysregulation at the
cell surface results in different forms of atypical hemolytic
uremic syndrome, and how this understanding may result in
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novel complement-modulating treatment approaches. In S. F.
Heeringa’s paper, the pathogenesis of complement associated
glomerulopathies is reviewed. Heeringa describes how defec-
tive complement control via the alternative pathway results
in glomerular C3 deposition and how this understanding has
generated a complement pan-blockade or plasma substitu-
tion as potential treatment strategies, which have been proven
successful.
H. Nishiura et al. shed further light on the importance
of the C5a receptor (C5aR) during erythropoiesis. Strikingly,
expression and regulation of RP S19 oligomer, which binds
to C5aR, may regulate C5aR function as a connector for the
erythroblast-macrophage island or for erythroblast differen-
tiation in the bone marrow.
D. Rittirsch et al. and �. Charcha�ieh et al. review
the highly elaborate immune response following trauma
and sepsis, which is—at least in part—driven by excessive
complement activation and may result in a deadly downward
spiral of SIRS, sepsis, septic shock, and multiorgan failure.
Recent clinical concepts, such as “damage control surgery,”
transition such �ndings into the clinical setting in an attempt
to improve outcome of a highly vulnerable patient popula-
tion.
ese manuscripts represent an exciting and insightful
snapshot of current complement research. State-of-the-art,
existing challenges, and emerging future topics are high-
lighted in this special issue, which may inspire the reader and
help advance the present complement research. We would
like to thank all authors, reviewers, and the Editor-in-Chief
for making this special issue in Clinical and Developmental
Immunology possible.
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